The key to developing sound research is creating diversity and joint-projects through shared knowledge, skills and financial support.
The following are some of the major research centres that RCSI Bahrain has collaborated with in recent years.
Arabian Gulf University (AGU) collaboration
Since 2015, principal investigators from each university annually submit projects that are jointly carried out.
2015/16 joint projects:
- Neuroprotective effects of gum Arabic in the ageing brain of diabetics.
- The impact of lifestyle and cardiovascular disease risk factors on arterial stiffness in a young healthy population of Arab descent.
2016/17 joint projects:
- Using nanotechnology for selective targeting of new curcumin derivatives for treatment of breast cancer
- Sigma-1 receptors – a novel target in the treatment of type 2 diabetes
2017/18 joint projects:
- Selective targeting of breast cancer cells by new Duocarmycin derivatives using nanotechnology.
- Diabetes and middle ear development.
2018/19 joint project:
- Lifestyle practices and beliefs of Bahraini women during pregnancy
University of Bahrain (UoB) collaboration
There has been historical collaboration with the University of Bahrain (UoB), which will be further enhanced with the newly added joint research fund of USD 50,000 from the academic year of 2020/2021 and 2021/2022.
Staff from both universities will collaborate through joint seminars, Masters supervision, sharing laboratory facilities and providing external examiners.
In October 2018, the institutions hosted their inaugural joint-research conference to great success
Collaboration with industry
Since 2014, RCSI Bahrain and SBI Pharmaceuticals have collaborated on research on 5-ALA, through projects and support for research fellows. Current research projects using 5-ALA with RCSI Bahrain are in the following three areas:
- Use of 5-ALA in diabetes
- Photodynamic screening of colorectal cancer patients using 5-ALA technology
- Ongoing research on using 5-ALA as a fungicide